我国抗癌药价格高昂的原因及相关措施研究

Research on the Reasons and the Related Measures for the High Price of Anticancer Drugs in China

目的:随着我国癌症患病人数的增多,癌症患者对于抗癌药的需求日益渐增,但抗癌药物过高的价格给患者带来了严重的经济和心理负担。这也是我国目前抗癌药物领域亟待解决的问题。本文旨在为降低抗癌药品的价格、减轻癌症患者的经济负担以及心理负担提供参考。方法:利用文献研究,分析我国抗癌药物价格高昂的具体原因,并从利益相关者的角度探索解决问题的途径,提出相应优化建议。结果与结论:我国抗癌药物的价格高昂的原因包含抗癌药的研发成本、专利费、关税和增值税、医院的加价、流转费用、市场因素等方面的影响因素。建议加快落实抗癌药物纳入医保报销目录、严格执行带量采购、加快新药上市等,实现减轻癌症患者经济和心理等各方面的负担,提高癌症患者抗癌药品可及性。

Objective:With the increasing number of cancer patients in China,the demand for anti-cancer drugs is increasing,but the high price of anti-cancer drugs brings serious economic and psychological burdens to patients.High price is also an urgent problem to be solved in the field of anticancer drugs in China.This paper aims to provide references for reducing the price of anticancer drugs and decreasing the economic and psychological burdens of cancer patients.Methods:By using literature research,the specific reasons for the high price of anticancer drugs in China were analyzed,and the corresponding suggestions for optimization were put forward from the perspective of stakeholders to explore the ways to solve the problems.Results and conclusion:The reasons for the high price of anticancer drugs in China include the R&D cost of anticancer drugs,patent fees,customs duties and value-added tax,hospital’s fare increase,circulation cost,market factors and so on.It is suggested that we should speed up the implementation of putting anti-cancer drugs into the medical insurance reimbursement catalogue,strictly implement the purchase with volume and push the marketing of new drugs,so as to reduce the economic and psychological burdens of cancer patients and improve the accessibility of anti-cancer drugs for cancer patients.